Plains GP Holdings (PAGP) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Feb, 2026Executive summary
Achieved Q4 2024 adjusted EBITDA of $729 million and full-year $2.78 billion, exceeding guidance by 4%.
Completed bolt-on acquisitions totaling ~$670 million, including Ironwood Midstream and the remaining 50% of Midway Pipeline, expanding the asset base.
Repurchased 12.7 million Series A Preferred Units (~18%) and increased annualized distribution by 20% to $1.52 per unit, yielding ~7.5%.
Reported 2024 net income attributable to unitholders of $36 million for Q4 and $772 million for the year, with net cash from operating activities of $726 million and $2.49 billion, respectively.
Financial highlights
Year-end 2024 leverage at 3.0x, below the target range of 3.25x–3.75x, with net debt at $7.27 billion and $2.6 billion committed liquidity.
2024 Adjusted Free Cash Flow (excluding changes in assets & liabilities) was $1.17 billion after distributions.
Q4 Adjusted EBITDA was $729 million, driven by higher crude volumes and pipeline tariff escalation.
Distribution per unit increased 20% in Q4 and 19% for the year.
Raised $1 billion in senior unsecured notes at 5.95% to fund acquisitions; $1 billion in notes mature in October 2025, expected to be refinanced.
Outlook and guidance
2025 Adjusted EBITDA guidance is $2.8–$2.95 billion, with crude oil segment growth and slightly lower NGL segment contributions.
2025 Adjusted Free Cash Flow expected at ~$1.15 billion, reduced by $580 million for bolt-on acquisitions.
Growth capital investment of ~$400 million and maintenance capital of ~$240 million planned for 2025.
Distribution increase to $1.52 per unit annualized, with further increases tied to bolt-on growth and base business performance.
Anticipate leverage at or below the low end of the 3.25x–3.75x target range.
Latest events from Plains GP Holdings
- Q2 2024 Adjusted EBITDA beat expectations; full-year guidance raised on strong execution.PAGP
Q2 20249 Feb 2026 - 2025 EBITDA reached $2.83B; 2026 targets $2.75B, with higher distributions and cost savings.PAGP
Q4 20256 Feb 2026 - Q3 Adjusted EBITDA $659M, leverage 3.0x, and Moody's upgrade support strong 2024 outlook.PAGP
Q3 202415 Jan 2026 - Strong 2024 results, disciplined capital returns, and robust governance drive value creation.PAGP
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and executive pay are up for vote at the 2025 meeting.PAGP
Proxy Filing2 Dec 2025 - Q1 2025 net income up 67%, Adjusted EBITDA $754M, strong growth and strategic acquisitions.PAGP
Q1 202526 Nov 2025 - Q2 Adjusted EBITDA $672M; NGL sale and acquisitions boost financial flexibility and focus.PAGP
Q2 202523 Nov 2025 - Q3 2025 EBITDA hit $669M; net income doubled, with acquisitions and NGL sale refocusing strategy.PAGP
Q3 202513 Nov 2025 - Raised 2024 EBITDA guidance and delivered strong free cash flow with efficient growth.PAGP
Investor Reception Presentation25 Jun 2025